Agios Pharmaceuticals

Agios Pharmaceuticals, based in Cambridge, MA, is a pioneering leader in cellular metabolism, dedicated to developing innovative therapies for patients with rare diseases, particularly focusing on hemolytic and acquired anemias. The company emphasizes collaboration with patient communities and healthcare professionals, ensuring that patient needs and insights are at the forefront of their therapeutic advancements.

With a strong commitment to maintaining a supportive and flexible work environment, Agios encourages its team members to bring their authentic selves to work, thereby fostering creativity and driving scientific discoveries. Their mission is centered around creating impactful therapies that provide long-term, disease-modifying effects for patients who face unmet medical needs.

Generated from the website